The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Identification of SARS-CoV-2 inhibitors using lung and colonic organoids
Open accessAbstract
There is an urgent need to create novel models using human disease-relevant cells to study severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) biology and to facilitate drug screening. Here, as SARS-CoV-2 primarily infects the respiratory tract, we developed a lung organoid model using human pluripotent stem cells (hPSC-LOs). The hPSC-LOs (particularly alveolar type-II-like cells) are permissive to SARS-CoV-2 infection, and showed robust induction of chemokines following SARS-CoV-2 infection, similar to what is seen in patients with COVID-19. Nearly 25% of these patients also have gastrointestinal manifestations, which are associated with worse COVID-19 outcomes 1. We therefore also generated complementary hPSC-derived colonic organoids (hPSC-COs) to explore the response of colonic cells to SARS-CoV-2 infection. We found that multiple colonic cell types, especially enterocytes, express ACE2 and are permissive to SARS-CoV-2 infection. Using hPSC-LOs, we performed a high-throughput screen of drugs approved by the FDA (US Food and Drug Administration) and identified entry inhibitors of SARS-CoV-2, including imatinib, mycophenolic acid and quinacrine dihydrochloride. Treatment at physiologically relevant levels of these drugs significantly inhibited SARS-CoV-2 infection of both hPSC-LOs and hPSC-COs. Together, these data demonstrate that hPSC-LOs and hPSC-COs infected by SARS-CoV-2 can serve as disease models to study SARS-CoV-2 infection and provide a valuable resource for drug screening to identify candidate COVID-19 therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“high-throughput screens of ≥1,000 drugs approved by the FDA run on colonic and lung organoids identified several SARS-CoV-2 entry inhibitors such as imatinib, mycophenolic acid and quinacrine dihydrochloride111.”
From Human disease models in drug development (2023) · cites this paper as [111]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“amodiaquine (for example, NCT04532931, NCT04502342)51 and imatinib111 (for example, NCT04394416) have entered clinical trials.”
From Human disease models in drug development (2023) · cites this paper as [111]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Comprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405
Self-citationImbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222
Self-citationWebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs
Liao, Y., Wang, J., Jaehnig, E. J., Shi, Z., & Zhang, B. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz401 · Cited by 3,144
Cell entry mechanisms of SARS-CoV-2
Shang, J., Wan, Y., Luo, C., Ye, G., Geng, Q., Auerbach, A., & Li, F. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003138117 · Cited by 3,142
Monteil, V., Kwon, H., Prado, P., Hagelkrüys, A., Wimmer, R. A., Stahl, M., Leopoldi, A., Garreta, E., Hurtado del Pozo, C., Prosper, F., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.004 · Cited by 2,122
Pan, L., Mu, M., Yang, P., Sun, Y., Wang, R., Yan, J., Li, P., Hu, B., Wang, J., Hu, C., et al. (2020) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000620 · Cited by 1,823
A molecular cell atlas of the human lung from single-cell RNA sequencing
Travaglini, K. J., Nabhan, A. N., Penland, L., Sinha, R., Gillich, A., Sit, R. V., Chang, S., Conley, S. D., Mori, Y., Seita, J., et al. (2020) · Nature · doi:10.1038/s41586-020-2922-4 · Cited by 1,730
Cited by
Sorted by citations
Items 501–532 of 532
The Application of Organoids in the Study of Antiviral Innate Immunity
Wu, T., Zheng, C., & Zou, X. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-4108-8_20
Yu, Y., Cao, J., Liu, R., Zhou, M., Wei, J., Zheng, H., Wang, W., & Li, G. (2024) · PubMed Central · doi:10.12122/j.issn.1673-4254.2024.11.20
Establishment and Application of a Model for SARS-CoV-2 Infection of Human Nasal Mucosa Organoid
Yu, Y., Chen, Z., Cao, J., Zhou, M., Wei, J., Zheng, H., Li, J., Wang, W., & Li, G. (2024) · Jundishapur Journal of Microbiology · doi:10.5812/jjm-155640
The potential of brain organoids in addressing the heterogeneity of synucleinopathies
Diao, X.-J., Soto, C. A., Wang, F., Wang, Y., Wu, Y., & Mukherjee, A. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05686-w
Peptide-Based Systems for Regenerative Medicine
Mirhaji, S. S., Pirhaghi, M., Soleimanpour, M., & Saboury, A. A. (2025) · Springer eBooks · doi:10.1007/978-3-031-87744-5_7
Bioengineering Organoids for Disease Modeling and Drug Discovery
Mandal, K., Wahane, S., Nihad, M., Mukherjee, A., Bisht, B., Mukhopadhyay, C., Bose, B., & Paul, M. K. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815238693125010003
Kim, B., Bat-Ulzii, A., Lim, T., Kim, J. W., Im, W. R., Rajoriya, S., Natasha, A., Misra, D., Hennisa, H., Kwag, N. Y., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-48854-z
Yan, J., Monlong, J., Cougoule, C., Lacroix‐Lamandé, S., & Wiedemann, A. (2024) · Figshare · doi:10.6084/m9.figshare.26113051
Yan, J., Monlong, J., Cougoule, C., Lacroix‐Lamandé, S., & Wiedemann, A. (2024) · Figshare · doi:10.6084/m9.figshare.26113156
Kim, G.-W., & Cho, Y.-H. (2026) · Organoid · doi:10.51335/organoid.2026.6.e1
Shan, Z., Li, J., Ye, Z., Chen, Y., Chen, J., Chen, Y., Wang, X., Gao, C., Jiang, S., & Zhang, N. (2026) · Virologica Sinica · doi:10.1016/j.virs.2026.02.002
Self-citationAdvances in Stem Cell-Derived Organoids for Treating and Understanding Lung Diseases
Raut, N., Paliwal, H., Prajapati, B. G., Desai, S. A., & Patel, V. P. (2026) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-025-00544-4 · Cited by 1
Next‐Generation Respiratory Models: Bridging the Gap Between Biology and Bioengineering
Lee, E., Youn, D. H., Song, K., Park, B., Lee, J., Kim, B., Huh, Y. S., & Kang, S. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202504615
Organoid Perturbations as Tools to Explore Cellular Function and Plasticity
Kohl, K. E., & Busslinger, G. A. (2026) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-120324-024252
The organoid revolution to assess mycobacterial pulmonary infections
Leon‐Icaza, S. A. (2022) · theses.fr (ABES) · doi:10.70675/6e135d5fzb953z4ffcz9041z2684784040ad
Exploration of autophagy modulation in cancer and infectious diseases
Bestion, E. (2021) · theses.fr (ABES) · doi:10.70675/3663f1cdz2637z4b11za0afza7e39569a2fc
Kishore, A., Chauhan, S., & Bathala, M. (2026) · Research Square · doi:10.21203/rs.3.rs-9351966/v1
Pang, L., Zou, J., Yuan, Z., Zhao, P., & Yi, Z. (2026) · Antiviral Research · doi:10.1016/j.antiviral.2026.106417
Sirenko, O., Michlmayr, A., Macha, P., Grund‐Gröschke, S., Tong, Z., Lim, A., Keidel, E., Gonzaga, B., Lindner, M., Fischer, V., et al. (2026) · SLAS TECHNOLOGY · doi:10.1016/j.slast.2026.100427
Robust generation of distal respiratory airway organoids by an engineered cuboid chip
Yin, J., Bi, Z., Dai, T., Meng, H., Shi, F., Sun, J., Xu, T., & Liu, H. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04522-y
Wang, Y., Nozhat, Z., Duan, T., Chen, S., Ni, Y., Wang, Y., Shen, C., & You, M. (2026) · Cancer Biome and Targeted Therapy · doi:10.66505/cbtt.v1i2.37
Self-citationLi, X., Tian, Y., Wu, Y., Jiang, Y., Wang, H., Han, S., Cui, L., Song, Z., Chen, H., & Hou, H. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2026.120306
Self-citationShang, X., Wang, Z., Yu, J., Zhang, R. R., Liu, D., Zou, S., Leung, K., Jia, J., Fan, Y., Chan, K., et al. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004107
The 3D landscape of infection: spatial organization and in vitro models
Goldmann, O., & Medina, E. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1898257
Makkar, S. K., Bhatia, S., Nguyen, N., & Wei, G. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1927806
Guo, C., & Zhu, L. (2026) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2026.103071
Jalil, A. T., Mohammed, M. K., & Hindi, N. K. K. (2026) · In vitro models · doi:10.1007/s44164-026-00155-5
Organoids: Current Applications and Future Directions
Leng, Y., Wang, Y., Cao, C., Deng, F., Lian, W., Chen, X., Lin, M., Zeng, Z., Mo, D., Li, S., et al. (2026) · MedComm · doi:10.1002/mco2.70965
Phelps, J., Orr, A., & Willerth, S. M. (2026) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2026.2742992
RNA-dependent RNA polymerase (RdRp): Structure, function, and antiviral targeting in RNA viruses
Liu, W., Feng, Y., Liu, F., Ding, C., Qiu, X., & Dai, J. (2026) · Antiviral Research · doi:10.1016/j.antiviral.2026.106544
Zielinska, D., Fol, M., & Druszczyńska, M. (2026) · Vaccines · doi:10.3390/vaccines14100908
BindingDB Entry 50014773: Colloidal Aggregators in Biochemical SARS-CoV-2 Repurposing Screens.
BindingDB (2023) · UC San Diego · doi:10.7270/q25h7m47
Metadata
- Authors
- Han, Y., Duan, X., Yang, L., Nilsson-Payant, B. E., Wang, P., Duan, F., Tang, X., Yaron, T. M., Zhang, T., Uhl, S., Bram, Y., Richardson, C., Zhu, J., Zhao, Z., Redmond, D., Houghton, S., Nguyen, D.-H. T., Xu, D., Wang, X., Jessurun, J., Borczuk, A., Huang, Y., Johnson, J. L., Liu, Y., Xiang, J., Wang, H., Cantley, L. C., tenOever, B. R., Ho, D. D., Pan, F. C., Evans, T., Chen, H. J., Schwartz, R. E., & Chen, S.
- Affiliations
- Weill Cornell Medicine (US)
- Shanghai Jiao Tong University (CN)
- Icahn School of Medicine at Mount Sinai (US)
- Aaron Diamond AIDS Research Center (US)
- University of Chicago (US)
- University of Illinois Chicago (US)
- Corresponding author
- Wang, Hui
- Cantley, Lewis C.
- tenOever, Benjamin R.
- Ho, David D.
- Pan, Fong Cheng
- Evans, Todd
- Chen, Huanhuan Joyce
- Schwartz, Robert E.
- Chen, Shuibing
- ORCID
- Han, Yuling
- Duan, Xiaohua
- Yang, Liuliu
- Nilsson-Payant, Benjamin E.
- Wang, Pengfei
- Duan, Fuyu
- Tang, Xuming
- Yaron, Tomer M.
- Zhang, Tuo
- Uhl, Skyler
- Bram, Yaron
- Zhu, Jiajun
- Redmond, David
- Houghton, Sean
- Nguyen, Duc-Huy T.
- Xu, Dong
- Wang, Xing
- Jessurun, Jose
- Borczuk, Alain
- Huang, Yaoxing
- Johnson, Jared L.
- Liu, Yuru
- Xiang, Jenny
- Wang, Hui
- Cantley, Lewis C.
- tenOever, Benjamin R.
- Ho, David D.
- Pan, Fong Cheng
- Evans, Todd
- Chen, Huanhuan Joyce
- Schwartz, Robert E.
- Chen, Shuibing
- Venue
- Nature
- Published
- 2020-10-28
- Volume
- 589
- Issue
- 7841
- Pages
- 270-275
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC8034380
- OpenAlex
- W3096177766
- Cited by
- 530
- References
- 33
- Citations by year
- 2026: 35 · 2025: 51 · 2024: 67 · 2023: 94 · 2022: 120 · 2021: 155 · 2020: 7
- FWCI
- 12.35
- Type
- journal article
- Language
- en
- Update notices
- correction (2024-05-29)
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- American Diabetes Association (7-20-COVID-211)
- Icahn School of Medicine at Mount Sinai
- Nature
- National Institutes of Health
- Defense Advanced Research Projects Agency (W911NF‐16‐C‐0050)
- Weill Cornell Medical College
- Advanced Research Projects Agency
- National Cancer Institute (R00CA226353, R01CA234614)
- National Institute of Allergy and Infectious Diseases (R01AI107301)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK124463, R01DK116075, R01DK119667, 1RO3DK117252, R01DK121072, DP3DK111907, R03DK117252)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Keywords
- SARS-CoV-2, COVID-19 pandemic, lung organoids, colonic organoids, human pluripotent stem cells, alveolar type II cells, enterocytes, ACE2 expression, entry inhibitors, imatinib, mycophenolic acid, high-throughput drug screening, FDA-approved drugs, antiviral activity, chemokine induction, gastrointestinal manifestations of COVID-19
- MeSH terms
- COVID-19, SARS-CoV-2, COVID-19 Drug Treatment, Animals, Antiviral Agents, Colon, Drug Evaluation, Preclinical, Female, Humans, Lung, Male, Organoids, United States, United States Food and Drug Administration, Drug Approval, Mice, Virus Internalization, Viral Tropism, Heterografts, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
